0001062993-23-014868.txt : 20230713
0001062993-23-014868.hdr.sgml : 20230713
20230713162137
ACCESSION NUMBER: 0001062993-23-014868
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230703
FILED AS OF DATE: 20230713
DATE AS OF CHANGE: 20230713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Yong Chan
CENTRAL INDEX KEY: 0001984332
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39101
FILM NUMBER: 231086995
MAIL ADDRESS:
STREET 1: C/O BAUDAX BIO, INC.
STREET 2: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Baudax Bio, Inc.
CENTRAL INDEX KEY: 0001780097
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 474639500
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-395-2470
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Recro Enterprises, Inc.
DATE OF NAME CHANGE: 20190618
3
1
form3.xml
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
X0206
3
2023-07-03
0
0001780097
Baudax Bio, Inc.
BXRX
0001984332
Kim Yong Chan
C/O BAUDAX BIO, INC.
490 LAPP ROAD
MALVERN
PA
19355
1
0
0
0
Common Stock
202260
D
Series X Preferred Stock
Common Stock
4520066
D
Shares of Series X Non-Voting Convertible Preferred Stock, par value $0.01 per share (the "Series X Preferred Stock"), shall automatically convert into the Issuer's common stock based on the Conversion Ratio and subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designations of Series X Non-Voting Convertible Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on July 5, 2023), effective as of 5:00 p.m. Eastern Time on the second trading day after the date on which the Issuer's stockholders approve the conversion of the Series X Preferred Stock.
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Jillian Dilmore, Attorney-in-fact
2023-07-13
EX-24.1
2
exhibit24-1.txt
POA
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that the undersigned hereby
constitutes and appoints Gerri Henwood and Jillian Dilmore of Baudax
Bio, Inc. (the "Company") with full power to act singly, as the
undersigned's true and lawful attorney-in-fact, with full power of
substitution, to:
1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director and/or
beneficial owner of the Company, Forms 3, 4, and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as
amended, and the rules thereunder;
2) do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to complete
and execute any such Form 3, 4, or 5, complete and execute any
amendment or amendments thereto, and timely file such form with
the United States Securities and Exchange Commission and any
stock exchange or similar authority; and
3) take any other action of any type whatsoever in
connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it being understood
that the documents executed by such attorney-in-fact on behalf
of the undersigned pursuant to this Power of Attorney shall be
in such form and shall contain such terms and conditions as
such attorney-in-fact may approve in such attorney-in-fact's
discretion.
The undersigned hereby grants to the attorneys-in-fact
full power and authority to do and perform any and every act and
thing whatsoever requisite, necessary or proper to be done in the
exercise of any of the rights and powers herein granted, as fully
to all intents and purposes as the undersigned might or could do
if personally present with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact or
such attorney-in-fact's substitute or substitutes, shall lawfully
do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted.
This power of attorney shall remain in full force and
effect until revoked by the undersigned in a signed writing
delivered to the attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 11th day of July, 2023.
/s/ Yong Chan Kim
Yong Chan Kim